Home Recalls D-0208-2025
Class III · Low risk Completed Initiated Jan 16, 2025 (2 years ago)
Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco…
Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.
Why it was recalled
Failed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet
What was recalled
Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma. LLC, NDC 43598-943-90.
Recalling firm Appco Pharma LLC
NDC code 43598-943-90
Origin NJ, United States
Initiated by Voluntary: Firm initiated
FDA recall number D-0208-2025
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Class II · Moderate risk Completed Mar 21, 2025
Reason Presence of Foreign Substance: Product complaint received for the presence of foreign material embedded resembling a metal shaving in one tablet.
Class II · Moderate risk Terminated Jun 21, 2024
Reason Failed Dissolution Specifications: Out-of-specification results observed for dissolution testing at the 8-hour and 12-hour pull intervals.
Class II · Moderate risk Terminated Jun 18, 2024
Reason Failed dissolution specifications: out of specification result obtained during routine stability testing for high dissolution.
Class II · Moderate risk Terminated Jul 29, 2021
Reason Presence of Forein Tablets/Capsules; Venlafaxine Tablets, USP 37.5 mg found in bottles labeled as Venlafaxine Tablets, USP, 50 mg
Class II · Moderate risk Terminated Mar 15, 2021
Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.